A5089205868- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Alcohol Consumption and Health Effects
- Hepatocellular Carcinoma Treatment and Prognosis
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Pressure Ulcer Prevention and Management
- Liver Diseases and Immunity
- Transplantation: Methods and Outcomes
- Viral gastroenteritis research and epidemiology
- Drug-Induced Hepatotoxicity and Protection
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Hepatitis B Virus Studies
- Intraperitoneal and Appendiceal Malignancies
- Hepatitis C virus research
- Diagnosis and Treatment of Venous Diseases
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Nutrition and Health in Aging
- Appendicitis Diagnosis and Management
- Multiple and Secondary Primary Cancers
- Healthcare cost, quality, practices
- Alcoholism and Thiamine Deficiency
- Foreign Body Medical Cases
- Cytomegalovirus and herpesvirus research
- Medication Adherence and Compliance
Northwestern University
2017-2024
Stanford University
1998-2022
Stanford Medicine
2020-2022
Mayo Clinic in Arizona
2020
Palo Alto University
2020
Stanford Health Care
2019
University of Calgary
2016-2017
Saint Louis University
2017
Creative Commons
2017
Alberta Innovates
2017
Abstract Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular carcinoma (HCC). The aim of this study was to explore incidence HCC in a cohort subjects with HBV and correlate treatment current guidance. We identified 2846 over period. diagnosed 386 (14%) subjects; 209 (54%) were on nucleos(t)ide analogue (NA) therapy at time diagnosis, 177 (46%) not NA therapy. Of NAs who developed during follow‐up, 153 (86%) had cirrhosis. Within NAs, 158 (89%) undetectable...
Abstract Background Malignancy-related ascites accounts for approximately 10% of causes ascites. Our AIM was to characterize the fluid and correlate clinical outcomes in those with extrahepatic malignancy Methods 241 subjects solid tumors were reviewed from 1/1/2000 12/31/2019, 119 without liver metastasis 122 metastasis. Results Ascites consistent peritoneal carcinomatosis (PC) most common, 150/241 (62%), followed by reflecting presence portal hypertension (PH), 69/241 (29%). 22/241 (9%)...
Liver transplantation (LT) is definitive treatment for end‐stage liver disease. This study evaluated factors predicting successful evaluation in patients transferred urgent inpatient LT evaluation. Eighty‐two with cirrhosis were from January 2016 to December 2018. Alcohol‐associated disease was the common etiology of (42/82). Of these 82 patients, 35 (43%) declined LT, 27 (33%) wait‐listed 5 (6%) improved, and 15 (18%) died. Psychosocial most reasons being (49%). Predictors listing receiving...
Background and aims Liver transplantation is a life-saving procedure for end-stage liver disease. However, post-transplant medication regimens are complex non-adherence common. Post-transplant associated with graft rejection, which can have long-term adverse consequences. Transplant centres equipped clinical staff that monitor patients post-transplant; however, digital health tools proactive immunosuppression adherence monitoring has potential to improve outcomes. Methods analysis This...
A 36-year-old man with obesity and dyslipidemia presented elevated liver enzymes following a transplant to treat acute-on-chronic failure due alcohol-associated hepatitis. What would you do next?
Background. Chronic kidney disease (CKD) is a well-recognized complication in patients undergoing liver transplantation (LT), particularly those with metabolic dysfunction-associated steatohepatitis (MASH), leading cause of cirrhosis the modern era. This study sought to refine risk stratification for CKD events post-LT MASH by leveraging baseline renal function at transplant. Methods. A total 717 who had LT (1997–2017) 7 US centers (NailMASH Consortium) were analyzed. Patients categorized...
Objective: Missing medical equipment in health care settings decrease productivity, increase spending to replace losses, and potentially endanger patient safety. By documenting investigating the causes of these incidents, strategies prevent future occurrences can be developed.Methods: As an example this approach, we describe inadvertent disposal expensive device during a randomized controlled trial (RCT) conducted within facility. The incident was carefully documented investigated shortly...
The lifetime risk of biliary tract cancer (BTC) in primary sclerosing cholangitis (PSC) patients exceeds 20% and BTC is currently the leading cause death PSC patients. To open new avenues for management PSC-associated (PSC-BTC), we aimed to delineate novel clinically relevant genomic pathological features a large cohort PSC-BTC tumor tissues.
Primary mucinous adenocarcinoma of the appendix is a rare gastrointestinal malignancy.Fistulous tract formation complication that cited in literature.An 85-year-old man with multiple comorbidities presented several weeks persistent non-bloody diarrhea.Laboratory work-up was non-diagnostic.Abdominal imaging barium contrast showed an enterocolonic fistulous extending from duodenum to cecum involving enlarged appendiceal mass.Subsequent biopsy confirmed neoplasm peritoneal spread liver and...